Equities

Arecor Therapeutics PLC

AREC:LSE

Arecor Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)131.00
  • Today's Change0.00 / 0.00%
  • Shares traded5.78k
  • 1 Year change-48.63%
  • Beta--
Data delayed at least 20 minutes, as of May 17 2024 15:44 BST.
More ▼
DateOpenHighLowCloseVolume
Friday, May 17, 2024Fri, May 17, 2024131.00135.00127.20131.005,7775.78k
Thursday, May 16, 2024Thu, May 16, 2024124.00138.00124.30131.0045,10645.11k
Wednesday, May 15, 2024Wed, May 15, 2024136.50140.00136.00136.5010,96910.97k
Tuesday, May 14, 2024Tue, May 14, 2024136.50140.00133.00136.504,8974.90k
Monday, May 13, 2024Mon, May 13, 2024136.50139.50133.10136.505,3085.31k
Friday, May 10, 2024Fri, May 10, 2024136.50139.18133.00136.50109,222109.22k
Thursday, May 09, 2024Thu, May 09, 2024135.00138.00136.15136.5014,06914.07k
Wednesday, May 08, 2024Wed, May 08, 2024137.50140.00133.35135.006,4946.49k
Tuesday, May 07, 2024Tue, May 07, 2024137.50140.00132.50137.5035,01135.01k
Friday, May 03, 2024Fri, May 03, 2024137.50137.95135.25137.5017,51817.52k
Thursday, May 02, 2024Thu, May 02, 2024137.50135.25135.00137.504,5004.50k
Wednesday, May 01, 2024Wed, May 01, 2024136.50137.00133.50137.5010,57610.58k
Tuesday, April 30, 2024Tue, Apr 30, 2024136.50139.86133.00136.5013,75013.75k
Monday, April 29, 2024Mon, Apr 29, 2024136.50133.14133.00136.502,5142.51k
Friday, April 26, 2024Fri, Apr 26, 2024136.50137.50133.00136.5019,48119.48k
Thursday, April 25, 2024Thu, Apr 25, 2024136.50137.80133.00136.5028,34628.35k
Wednesday, April 24, 2024Wed, Apr 24, 2024134.00138.00133.00136.5022,70022.70k
Tuesday, April 23, 2024Tue, Apr 23, 2024132.50135.00130.00132.5010,87610.88k
Monday, April 22, 2024Mon, Apr 22, 2024128.50132.36127.00132.5018,77418.77k
Data delayed at least 20 minutes, as of May 17 2024 16:44 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.